Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 196 entries
View as:

Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.

Phase: N/A Priority: Normal
NCT ID: NCT06786299 Org: User:
Start: 02/10/25 End: 12/31/26 Due: 12/31/27

Stent Implantation for Patients With SIDSMA

Phase: N/A Priority: Normal
NCT ID: NCT03916965 Org: User:
Start: 04/01/19 End: 12/30/23 Due: 12/30/24

Dorsal Vetilation and PPCs in Colorectal Cancer Surgery Patients

Phase: N/A Priority: Normal
NCT ID: NCT06662799 Org: User:
Start: 07/01/24 End: 12/25/24 Due: 12/25/25

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT05084027 Org: User:
Start: 10/07/21 End: 09/30/24 Due: 09/30/25

HD-tDCS Combined With Circadian Rhythm Reconstruction and Micro Expression Changes on Consciousness Recovery in Patients With Chronic Disturbance of Consciousness

Phase: N/A Priority: Normal
NCT ID: NCT05285124 Org: User:
Start: 07/01/21 End: 12/31/24 Due: 12/31/25

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

Phase: N/A Priority: Normal
NCT ID: NCT04261907 Org: User:
Start: 02/11/20 End: 04/13/20 Due: 04/13/21

Use of One Kind of Controllable Tube Ileostomy in the Low Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02012023 Org: User:
Start: 01/31/14 End: 08/31/16 Due: 08/31/17

Universal CNK-UT Therapy for Refractory aGVHD

Phase: N/A Priority: Normal
NCT ID: NCT06750133 Org: User:
Start: 12/14/24 End: 06/30/26 Due: 06/30/27

The Usage of High-resolution Magnetic Resonance Imaging in Patients With Post-stroke Aphasia for Predicting the Outcome

Phase: N/A Priority: Normal
NCT ID: NCT03475745 Org: User:
Start: 11/20/17 End: 06/30/20 Due: 06/30/21

Effect of Lateral Positions on the Shape of Upper Airway

Phase: N/A Priority: Normal
NCT ID: NCT06236971 Org: User:
Start: 02/05/24 End: 03/29/24 Due: 03/29/25

Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06385106 Org: User:
Start: 03/16/24 End: 01/31/26 Due: 01/31/27

Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06516991 Org: User:
Start: 07/16/24 End: 09/30/24 Due: 09/30/25

Chidamide With R-CHOP Regimen for DLBCL Patients

Phase: N/A Priority: Normal
NCT ID: NCT03201471 Org: User:
Start: 08/20/17 End: 02/05/20 Due: 02/05/21

Impacts of Different ART Regimens on Lipid Metabolism in People Living With HIV

Phase: N/A Priority: Normal
NCT ID: NCT06019273 Org: User:
Start: 04/25/22 End: 05/01/24 Due: 05/01/25

Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL

Phase: N/A Priority: Normal
NCT ID: NCT06754267 Org: User:
Start: 12/31/24 End: 12/30/27 Due: 12/30/28

Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS

Phase: N/A Priority: Normal
NCT ID: NCT06050941 Org: User:
Start: 04/02/24 End: 04/02/27 Due: 04/02/28

Transcranial Alternating Current Stimulation in Patients With Disorders of Consciousness

Phase: N/A Priority: Normal
NCT ID: NCT06211439 Org: User:
Start: 12/05/22 End: 10/31/24 Due: 10/31/25

VHAG in Treating R/R T-ALL/LBL

Phase: N/A Priority: Normal
NCT ID: NCT06742463 Org: User:
Start: 12/31/24 End: 06/30/28 Due: 06/30/29

Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL

Phase: N/A Priority: Normal
NCT ID: NCT06742515 Org: User:
Start: 10/17/24 End: 08/31/28 Due: 08/31/29

Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL

Phase: N/A Priority: Normal
NCT ID: NCT06554626 Org: User:
Start: 08/15/24 End: 08/01/27 Due: 08/01/28

Bioequivalence Study (Preliminary Study) of Ritonavir Versus NORVIR in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03214159 Org: User:
Start: 07/11/17 End: 09/20/17 Due: 09/20/18

Augmentation of Interpersonal Psychotherapy With High-Definition Transcranial Direct Current Stimulation for Adolescent Depression

Phase: N/A Priority: Normal
NCT ID: NCT06061653 Org: User:
Start: 10/01/23 End: 12/31/25 Due: 12/31/26

Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)

Phase: N/A Priority: Normal
NCT ID: NCT06611813 Org: User:
Start: 06/11/24 End: 06/30/29 Due: 06/30/30

Transcranial Magnetic Stimulation in Patients With Disorders of Consciousness

Phase: N/A Priority: Normal
NCT ID: NCT03385278 Org: User:
Start: 04/30/15 End: 02/28/18 Due: 02/28/19

Positron Emission Tomography in Transcranial Magnetic Stimulation Intervention for Treatment-resistant Depression

Phase: N/A Priority: Normal
NCT ID: NCT06044324 Org: User:
Start: 11/01/23 End: 05/01/26 Due: 05/01/27